| Financial Year |
March 31 2023 |
| Monetary Funds |
5,939,843,775.00 |
| Held-for-trading Financial Assets |
621,999,325.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
5,754,655,592.00 |
| Advances to Suppliers |
572,566,494.00 |
| Other Receivables |
267,781,799.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,274,550.00 |
| Dividend Receivable |
-- |
| Inventories |
3,146,557,673.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
422,271,279.00 |
| Total Current Assets |
18,385,080,642.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,838,331,545.00 |
| Investment Properties |
-- |
| Fixed Assetes |
9,915,172,265.00 |
| Under-construction Projects |
1,225,973,970.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,224,901,638.00 |
| R&D expenses |
145,184,790.00 |
| Goodwill |
98,659,994.00 |
| Long-Term Deferred and Prepaid Expenses |
64,611,090.00 |
| Deferred Income Tax Assets |
625,897,057.00 |
| Other Non-Current Assets |
300,864,883.00 |
| Sub-Total of Non-Current Assets |
17,720,423,863.00 |
| Total Assets |
36,105,504,505.00 |
| Short-Term Loans |
3,762,849,570.00 |
| Trading Financial liabilities |
1,084,237.00 |
| Notes Payable |
139,309,604.00 |
| Accounts Payable |
1,912,767,129.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
167,288,811.00 |
| Taxes Payable |
245,518,110.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,855,293,461.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,089,488,231.00 |
| Other Current Liabilities |
830,929,230.00 |
| Sub-Total of Current Liabilities |
13,013,306,742.00 |
| Long-term Loans |
1,840,479,996.00 |
| Bonds Payable |
1,938,318,555.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,512,542.00 |
| Deferred Income Tax Liabilities |
263,868,716.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,496,764,284.00 |
| Total Liabilities |
17,510,071,026.00 |
| Paid-In Capital(Or Share Stock) |
1,471,269,780.00 |
| Capital Surplus |
3,713,249,424.00 |
| Surplus Reserve |
1,230,157,429.00 |
| LESS:Treasury Stock |
237,075,644.00 |
| Undistributed Profits |
10,018,755,836.00 |
| Minority Stockholder's Interest |
2,071,748,378.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,523,685,101.00 |
| Owner's Equity（Stockholder's Equity） |
18,595,433,479.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,105,504,505.00 |
